PI3K pathway inhibitors approach junction

被引:44
|
作者
Holmes, David
机构
关键词
D O I
10.1038/nrd3527
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:563 / 565
页数:3
相关论文
共 50 条
  • [1] PI3K pathway inhibitors approach junction
    David Holmes
    Nature Reviews Drug Discovery, 2011, 10 : 563 - 564
  • [2] Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors
    Tabernero, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [3] PI3K Pathway Inhibitors: Better Not Left Alone
    Markman, Ben
    Tao, Jessica J.
    Scaltriti, Maurizio
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (05) : 895 - 906
  • [4] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [5] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [6] Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers
    Ibanez, Kristen R.
    Huang, Tzu-Ting
    Lee, Jung-Min
    CELLS, 2024, 13 (12)
  • [7] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 335 - 342
  • [8] Targeting cancer with PI3K pathway inhibitors: who to aim at?
    Kinross, Kathryn M.
    Sheppard, Karen E.
    Pearson, Richard B.
    Phillips, Wayne A.
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (02) : 119 - 121
  • [9] Current clinical development of PI3K pathway inhibitors in glioblastoma
    Wen, Patrick Y.
    Lee, Eudocia Q.
    Reardon, David A.
    Ligon, Keith L.
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2012, 14 (07) : 819 - 829
  • [10] Imidazopyridazine Inhibitors of PI3Kβ
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1012 - 1013